<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03316170</url>
  </required_header>
  <id_info>
    <org_study_id>MCC-17-0495-P3K</org_study_id>
    <nct_id>NCT03316170</nct_id>
  </id_info>
  <brief_title>Consultation, Advice, and Tailored Support (CATS) for Cancer Survivors</brief_title>
  <official_title>Consultation, Advice, and Tailored Support (CATS) for Cancer Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jessica Burris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kentucky Lung Cancer Research Program</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this pilot clinical trial are: 1) To evaluate the feasibility and&#xD;
      acceptability of a new approach to smoking cessation induction treatment in cancer survivors&#xD;
      with low social resources, and 2) To assess the effectiveness of said treatment for key&#xD;
      events in the process of smoking cessation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot (Phase II) randomized clinical trial with randomization in a 1:1 ratio. The&#xD;
      control group will receive a brief consultation (10-15 minutes via phone) about free or&#xD;
      low-cost resources that may help them address unmet social support needs. Additionally, a&#xD;
      written directory of a range of social support resources will be delivered to them via mail.&#xD;
      The treatment group will receive the aforesaid intervention plus brief advice to quit smoking&#xD;
      (10-15 minutes via phone). Additionally, a written summary of the benefits of smoking&#xD;
      cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy&#xD;
      (NRT) will be provided via mail. The treatment group will also receive a free, 2-week supply&#xD;
      of nicotine patches and lozenges delivered via mail. As a pilot, this study focuses on the&#xD;
      outcomes of feasibility (i.e., accrual and retention) and acceptability (e.g., participants'&#xD;
      perceptions of appropriateness and effectiveness) as opposed to efficacy (though this is also&#xD;
      important). The emphasis on smoking cessation induction (that is, the inducement or promotion&#xD;
      of a quit attempt) is an important aspect of the study design and is appropriate for smokers&#xD;
      across the continuum of motivation to quit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 6, 2017</start_date>
  <completion_date type="Actual">March 31, 2020</completion_date>
  <primary_completion_date type="Actual">March 31, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accrual Percentage</measure>
    <time_frame>Day 0 baseline</time_frame>
    <description>Accrual percentage = (number participants enrolled / number individuals contacted about study participation) multiplied by 100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention</measure>
    <time_frame>Through study completion, number of assessments at Day 60 follow-up</time_frame>
    <description>Retention percentage = (number with complete assessments at end of study / number participants enrolled) multiplied by 100</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability</measure>
    <time_frame>Day 60 follow-up</time_frame>
    <description>Total score on the Treatment Acceptability and Preferences measure (Sidani et al., 2009). This is a 4-item measure with each item scored on a scale from 0 to 4. Total scores are computed as the mean of the 4 individual items, so total scores range from 0 to 4. Higher scores indicate a better outcome, as they reflect greater acceptability of the treatment provided in this clinical trial.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">49</enrollment>
  <condition>Smoking Cessation</condition>
  <condition>Social Stress</condition>
  <arm_group>
    <arm_group_label>Social Support + NRT Sampling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The treatment group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
a brief phone consult (10-15 minutes via phone) germane to smoking cessation,&#xD;
a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and&#xD;
a free, 2-week supply of nicotine patches and lozenges delivered via mail.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Social Support</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Support</intervention_name>
    <description>A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.</description>
    <arm_group_label>Social Support</arm_group_label>
    <arm_group_label>Social Support + NRT Sampling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>NRT Sampling</intervention_name>
    <description>A brief phone consult (10-15 minutes via phone) germane to smoking cessation akin to &quot;brief advice&quot;, a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and a free, 2-week supply of nicotine patches and lozenges delivered via mail.</description>
    <arm_group_label>Social Support + NRT Sampling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cervical or head/neck cancer diagnosis in the past 5 years&#xD;
&#xD;
          -  Resident of rural and/or Appalachian Kentucky county at cancer diagnosis&#xD;
&#xD;
          -  Current smoker of â‰¥ 10 cigarettes per day, on average&#xD;
&#xD;
          -  Age 18-75 years old&#xD;
&#xD;
          -  Able to read, write, and understand English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unreliable phone access&#xD;
&#xD;
          -  Smoking cessation treatment use in past 30 days&#xD;
&#xD;
          -  Non-cigarette tobacco use in the past 30 days&#xD;
&#xD;
          -  Any FDA contraindication for NRT use, including: allergy to nicotine patches and/or&#xD;
             nicotine lozenges; severe kidney or liver disease; unstable angina or serious&#xD;
             arrhythmia; epilepsy or seizure disorder; myocardial infarction in the past 3 months&#xD;
&#xD;
          -  Cognitive or psychiatric disorder that would interfere with ability to provide&#xD;
             informed consent or answer survey questions reliably *&#xD;
&#xD;
             * Any of these Diagnostic and Statistical Manual-5 (DSM-5) cognitive and psychiatric&#xD;
             disorders would make someone ineligible: bipolar; delusional; dissociative;&#xD;
             intellectual developmental; neurocognitive; psychotic; schizophreniform,&#xD;
             schizophrenia, and schizoaffective.&#xD;
&#xD;
          -  For women: breastfeeding, pregnancy, or plan to become pregnant within 6 months&#xD;
&#xD;
          -  For women of childbearing potential: unwillingness to use an effective method of birth&#xD;
             control (e.g., abstinence, oral contraceptive) while in this study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jessica Burris, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Kentucky Markey Cancer Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sidani S, Epstein DR, Bootzin RR, Moritz P, Miranda J. Assessment of preferences for treatment: validation of a measure. Res Nurs Health. 2009 Aug;32(4):419-31. doi: 10.1002/nur.20329.</citation>
    <PMID>19434647</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>September 26, 2017</study_first_submitted>
  <study_first_submitted_qc>October 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2017</study_first_posted>
  <results_first_submitted>March 23, 2021</results_first_submitted>
  <results_first_submitted_qc>June 16, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 8, 2021</results_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>Jessica Burris</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 21, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT03316170/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Social Support + NRT Sampling</title>
          <description>The treatment group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
a brief phone consult (10-15 minutes via phone) germane to smoking cessation,&#xD;
a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and&#xD;
a free, 2-week supply of nicotine patches and lozenges delivered via mail.&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.&#xD;
NRT Sampling: A brief phone consult (10-15 minutes via phone) germane to smoking cessation akin to &quot;brief advice&quot;, a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and a free, 2-week supply of nicotine patches and lozenges delivered via mail.</description>
        </group>
        <group group_id="P2">
          <title>Social Support</title>
          <description>The control group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Each participant is 1 unit in the analysis</population>
      <group_list>
        <group group_id="B1">
          <title>Social Support + NRT Sampling</title>
          <description>The treatment group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
a brief phone consult (10-15 minutes via phone) germane to smoking cessation,&#xD;
a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and&#xD;
a free, 2-week supply of nicotine patches and lozenges delivered via mail.&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.&#xD;
NRT Sampling: A brief phone consult (10-15 minutes via phone) germane to smoking cessation akin to &quot;brief advice&quot;, a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and a free, 2-week supply of nicotine patches and lozenges delivered via mail.</description>
        </group>
        <group group_id="B2">
          <title>Social Support</title>
          <description>The control group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="24"/>
            <count group_id="B2" value="25"/>
            <count group_id="B3" value="49"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>1 participant did not report their age</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="23"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="48"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.78" spread="9.27"/>
                    <measurement group_id="B2" value="56.00" spread="10.00"/>
                    <measurement group_id="B3" value="55.42" spread="9.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Distress Thermometer (NCCN)</title>
          <description>The National Comprehensive Cancer Network (NCCN) Distress Thermometer is a single-item measure of overall distress where people respond on a 11-point scale from 0 to 10. Higher scores indicate a worse outcome, as they reflect more distress.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="24"/>
                    <count group_id="B2" value="25"/>
                    <count group_id="B3" value="49"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.21" spread="2.95"/>
                    <measurement group_id="B2" value="4.72" spread="3.45"/>
                    <measurement group_id="B3" value="4.47" spread="3.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Accrual Percentage</title>
        <description>Accrual percentage = (number participants enrolled / number individuals contacted about study participation) multiplied by 100</description>
        <time_frame>Day 0 baseline</time_frame>
        <population>Across all recruitment methods, a total of 551 individuals were contacted about the study; this number is not tied to study arm. Of these 551 individuals, a subset met the eligibility criteria, enrolled in the study, and were then randomized into one of the study arms.</population>
        <group_list>
          <group group_id="O1">
            <title>All Individuals Contacted</title>
            <description>All individuals who were contacted about the study.</description>
          </group>
        </group_list>
        <measure>
          <title>Accrual Percentage</title>
          <description>Accrual percentage = (number participants enrolled / number individuals contacted about study participation) multiplied by 100</description>
          <population>Across all recruitment methods, a total of 551 individuals were contacted about the study; this number is not tied to study arm. Of these 551 individuals, a subset met the eligibility criteria, enrolled in the study, and were then randomized into one of the study arms.</population>
          <units>percentage of participants enrolled</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="551"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Retention</title>
        <description>Retention percentage = (number with complete assessments at end of study / number participants enrolled) multiplied by 100</description>
        <time_frame>Through study completion, number of assessments at Day 60 follow-up</time_frame>
        <population>Participants enrolled in the study</population>
        <group_list>
          <group group_id="O1">
            <title>Social Support + NRT Sampling</title>
            <description>The treatment group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
a brief phone consult (10-15 minutes via phone) germane to smoking cessation,&#xD;
a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and&#xD;
a free, 2-week supply of nicotine patches and lozenges delivered via mail.&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.&#xD;
NRT Sampling: A brief phone consult (10-15 minutes via phone) germane to smoking cessation akin to &quot;brief advice&quot;, a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and a free, 2-week supply of nicotine patches and lozenges delivered via mail.</description>
          </group>
          <group group_id="O2">
            <title>Social Support</title>
            <description>The control group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.</description>
          </group>
        </group_list>
        <measure>
          <title>Retention</title>
          <description>Retention percentage = (number with complete assessments at end of study / number participants enrolled) multiplied by 100</description>
          <population>Participants enrolled in the study</population>
          <units>percentage of participant w/ assessments</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.8"/>
                    <measurement group_id="O2" value="72.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Acceptability</title>
        <description>Total score on the Treatment Acceptability and Preferences measure (Sidani et al., 2009). This is a 4-item measure with each item scored on a scale from 0 to 4. Total scores are computed as the mean of the 4 individual items, so total scores range from 0 to 4. Higher scores indicate a better outcome, as they reflect greater acceptability of the treatment provided in this clinical trial.</description>
        <time_frame>Day 60 follow-up</time_frame>
        <population>Analysis based on participants who completed the Day 60 assessment and provided data for this outcome</population>
        <group_list>
          <group group_id="O1">
            <title>Social Support + NRT Sampling</title>
            <description>The treatment group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
a brief phone consult (10-15 minutes via phone) germane to smoking cessation,&#xD;
a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and&#xD;
a free, 2-week supply of nicotine patches and lozenges delivered via mail.&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.&#xD;
NRT Sampling: A brief phone consult (10-15 minutes via phone) germane to smoking cessation akin to &quot;brief advice&quot;, a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and a free, 2-week supply of nicotine patches and lozenges delivered via mail.</description>
          </group>
          <group group_id="O2">
            <title>Social Support</title>
            <description>The control group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.</description>
          </group>
        </group_list>
        <measure>
          <title>Acceptability</title>
          <description>Total score on the Treatment Acceptability and Preferences measure (Sidani et al., 2009). This is a 4-item measure with each item scored on a scale from 0 to 4. Total scores are computed as the mean of the 4 individual items, so total scores range from 0 to 4. Higher scores indicate a better outcome, as they reflect greater acceptability of the treatment provided in this clinical trial.</description>
          <population>Analysis based on participants who completed the Day 60 assessment and provided data for this outcome</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.84" spread="1.09"/>
                    <measurement group_id="O2" value="1.98" spread="1.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>.06</p_value>
            <method>t-test, 2 sided</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.86</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.44</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.75</ci_lower_limit>
            <ci_upper_limit>0.30</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Approximately 2 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Social Support + NRT Sampling</title>
          <description>The treatment group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
a brief phone consult (10-15 minutes via phone) germane to smoking cessation,&#xD;
a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and&#xD;
a free, 2-week supply of nicotine patches and lozenges delivered via mail.&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.&#xD;
NRT Sampling: A brief phone consult (10-15 minutes via phone) germane to smoking cessation akin to &quot;brief advice&quot;, a written summary of the benefits of smoking cessation, evidence-based approaches to quit, and the basics of nicotine replacement therapy (NRT) delivered via mail, and a free, 2-week supply of nicotine patches and lozenges delivered via mail.</description>
        </group>
        <group group_id="E2">
          <title>Social Support</title>
          <description>The control group will receive:&#xD;
a brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs,&#xD;
a written directory of a range of social support resources delivered via mail,&#xD;
Social Support: A brief phone consultation (10-15 minutes via phone) about free or low-cost resources that may help them address unmet social support needs, and a written directory of a range of social support resources delivered via mail.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="10" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Irregular heartbeat</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Rapid heartbeat</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Heartburn</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Hiccups</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Vomiting or nausea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Burning in throat or mouth</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Dry mouth</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Excessive saliva</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Sore mouth</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Sore throat</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Weakness</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing difficulty</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin irritation</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin itchiness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin redness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Skin swelling</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Jessica Burris</name_or_title>
      <organization>University of Kentucky</organization>
      <phone>+1 859-257-9612</phone>
      <email>jessica.burris@uky.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

